Dr. Harrington currently serves as CEO of Aviir, Inc, a Stanford University spin-out cardiac biomarker company. He holds multiple professional affiliation memberships including the American Medical Association, the American Society of Clinical Pathologists, the College of American Pathologists, the Association for Molecular Pathology and the International Academy of Pathology. Dr. Harrington received his B.A. in Molecular Biology and M.D. from the University of Colorado. He is Board Certified in Anatomic and Clinical Pathology and Hematology and has authored numerous peer-reviewed publications
for his full bio click here